| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | type I interferon receptor binding | 2.94e-07 | 17 | 177 | 5 | GO:0005132 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MAGI1 XIRP1 MAP7D3 MYO5B TOM1 CKAP5 DYRK1A SPAG5 ADORA2A EEF2 NDRG1 BRCA2 CEP44 SCN5A NAV3 SNTG1 CDK5RAP2 MACF1 TLN2 DLEC1 TNS4 FERMT2 USH2A | 1.13e-04 | 1099 | 177 | 23 | GO:0008092 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO5B CHD8 UPF1 XRCC3 SMC5 ABCA10 DNAH1 FBH1 HELZ2 NAV3 NAV2 MACF1 DNAH8 DDX39B DYNC1H1 TOP2B | 1.19e-04 | 614 | 177 | 16 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYO5B CHD8 UPF1 SMC5 ABCA10 FBH1 HELZ2 NAV3 NAV2 MACF1 DNAH8 DDX39B DYNC1H1 | 1.61e-04 | 441 | 177 | 13 | GO:0016887 |
| GeneOntologyBiologicalProcess | type I interferon-mediated signaling pathway | 6.15e-08 | 85 | 182 | 9 | GO:0060337 | |
| GeneOntologyBiologicalProcess | cellular response to type I interferon | 6.82e-08 | 86 | 182 | 9 | GO:0071357 | |
| GeneOntologyBiologicalProcess | response to type I interferon | 1.23e-07 | 92 | 182 | 9 | GO:0034340 | |
| GeneOntologyBiologicalProcess | interferon-mediated signaling pathway | 6.70e-07 | 112 | 182 | 9 | GO:0140888 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation of STAT protein | 9.19e-07 | 21 | 182 | 5 | GO:0033141 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation of STAT protein | 1.88e-06 | 24 | 182 | 5 | GO:0033139 | |
| GeneOntologyBiologicalProcess | serine phosphorylation of STAT protein | 4.22e-06 | 28 | 182 | 5 | GO:0042501 | |
| GeneOntologyBiologicalProcess | centrosome duplication | 7.44e-06 | 81 | 182 | 7 | GO:0051298 | |
| GeneOntologyBiologicalProcess | cellular response to virus | 1.50e-05 | 90 | 182 | 7 | GO:0098586 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus by host | 1.95e-05 | 63 | 182 | 6 | GO:0050691 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation | 3.17e-05 | 101 | 182 | 7 | GO:0033138 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 3.31e-05 | 42 | 182 | 5 | GO:0002323 | |
| GeneOntologyBiologicalProcess | B cell activation | FLT3 GON4L CASP8 IFNA4 IFNA7 IFNA10 IFNA14 IFNA21 PKN1 TOP2B TP53BP1 NCKAP1L | 5.31e-05 | 341 | 182 | 12 | GO:0042113 |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | CKAP5 DYRK1A CEP192 ODAD2 XRCC3 SPAG5 NAV3 CDK5RAP2 MACF1 CFAP69 DYNC1H1 | 6.15e-05 | 293 | 182 | 11 | GO:0032886 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | MAP7D3 CKAP5 DYRK1A CEP192 ODAD2 XRCC3 KIAA1614 SPAG5 DNAH1 BRCA2 CEP44 NAV3 CDK5RAP2 SPAG17 CFAP69 DNAH8 DYNC1H1 DEUP1 | 7.19e-05 | 720 | 182 | 18 | GO:0000226 |
| GeneOntologyBiologicalProcess | B cell differentiation | 7.67e-05 | 201 | 182 | 9 | GO:0030183 | |
| GeneOntologyBiologicalProcess | positive regulation of cytoskeleton organization | NCKAP1 CKAP5 SPAG5 NAV3 CDK5RAP2 PRKD1 FERMT2 DYNC1H1 NCKAP1L | 8.92e-05 | 205 | 182 | 9 | GO:0051495 |
| GeneOntologyBiologicalProcess | centrosome cycle | 1.07e-04 | 164 | 182 | 8 | GO:0007098 | |
| GeneOntologyBiologicalProcess | response to virus | FLT3 LAMTOR5 TRIM41 USP29 OAS2 IFNA4 IFNA7 STAT2 IFNA10 IFNA14 CHUK IFNA21 MICB | 1.08e-04 | 425 | 182 | 13 | GO:0009615 |
| GeneOntologyBiologicalProcess | natural killer cell activation | 1.17e-04 | 124 | 182 | 7 | GO:0030101 | |
| GeneOntologyBiologicalProcess | B cell proliferation | 1.17e-04 | 124 | 182 | 7 | GO:0042100 | |
| GeneOntologyBiologicalProcess | response to exogenous dsRNA | 1.23e-04 | 55 | 182 | 5 | GO:0043330 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via STAT | 1.33e-04 | 216 | 182 | 9 | GO:0097696 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus | 1.46e-04 | 90 | 182 | 6 | GO:0050688 | |
| GeneOntologyBiologicalProcess | microtubule-based process | MAP7D3 CKAP5 DYRK1A FYCO1 CEP192 ODAD2 XRCC3 KIAA1614 SPAG5 DNAH1 CFAP54 BRCA2 CEP44 NAV3 CDK5RAP2 MACF1 RABGEF1 SPAG17 CFAP69 DNAH8 DYNC1H1 DEUP1 | 1.67e-04 | 1058 | 182 | 22 | GO:0007017 |
| GeneOntologyBiologicalProcess | DNA conformation change | 1.86e-04 | 94 | 182 | 6 | GO:0071103 | |
| GeneOntologyBiologicalProcess | cytokine-mediated signaling pathway | FLT3 GPR17 TRIM41 USP29 CASP8 OAS2 IFNA4 IFNA7 STAT2 IFNA10 IFNA14 CHUK IFNA21 RABGEF1 OSMR | 1.93e-04 | 577 | 182 | 15 | GO:0019221 |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | 1.95e-04 | 179 | 182 | 8 | GO:0031023 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation | 2.18e-04 | 137 | 182 | 7 | GO:0033135 | |
| GeneOntologyBiologicalProcess | positive regulation of amino acid transport | 2.21e-04 | 34 | 182 | 4 | GO:0051957 | |
| GeneOntologyBiologicalProcess | vagus nerve development | 2.31e-04 | 3 | 182 | 2 | GO:0021564 | |
| GeneOntologyBiologicalProcess | response to dsRNA | 2.35e-04 | 63 | 182 | 5 | GO:0043331 | |
| GeneOntologyBiologicalProcess | defense response to virus | TRIM41 USP29 OAS2 IFNA4 IFNA7 STAT2 IFNA10 IFNA14 CHUK IFNA21 MICB | 2.39e-04 | 342 | 182 | 11 | GO:0051607 |
| GeneOntologyBiologicalProcess | double-strand break repair via homologous recombination | 2.72e-04 | 188 | 182 | 8 | GO:0000724 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via STAT | 2.83e-04 | 143 | 182 | 7 | GO:1904892 | |
| GeneOntologyBiologicalProcess | telomere maintenance via recombination | 2.84e-04 | 15 | 182 | 3 | GO:0000722 | |
| GeneOntologyBiologicalProcess | recombinational repair | 3.36e-04 | 194 | 182 | 8 | GO:0000725 | |
| GeneOntologyBiologicalProcess | regulation of cell morphogenesis | 3.64e-04 | 302 | 182 | 10 | GO:0022604 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via JAK-STAT | 3.85e-04 | 198 | 182 | 8 | GO:0007259 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | DYRK1A IFNA4 IFNA7 IFNA10 IFNA14 CHUK IFNA21 PKN1 PRKD1 PHIP | 4.15e-04 | 307 | 182 | 10 | GO:0018105 |
| GeneOntologyBiologicalProcess | regulation of cell shape | 5.37e-04 | 159 | 182 | 7 | GO:0008360 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | DYRK1A IFNA4 IFNA7 IFNA10 IFNA14 CHUK IFNA21 PKN1 PRKD1 PHIP | 5.59e-04 | 319 | 182 | 10 | GO:0018209 |
| GeneOntologyBiologicalProcess | regulation of response to external stimulus | GPR17 TRIM41 USP29 CASP8 CHD8 F2 RNF115 IFNA4 IFNA7 STAT2 IFNA10 IFNA14 CHUK IFNA21 ADORA2A PIK3R6 MICB PLXNA4 RABGEF1 PRKD1 OSMR STK24 VEGFA NCKAP1L | 5.76e-04 | 1316 | 182 | 24 | GO:0032101 |
| GeneOntologyBiologicalProcess | positive regulation of organelle organization | NCKAP1 TOM1 CKAP5 FYCO1 SMC5 MCOLN1 SPAG5 NAV3 CDK5RAP2 PRKD1 FERMT2 PHIP DYNC1H1 NCKAP1L | 5.95e-04 | 574 | 182 | 14 | GO:0010638 |
| GeneOntologyBiologicalProcess | microtubule polymerization | 6.05e-04 | 117 | 182 | 6 | GO:0046785 | |
| GeneOntologyBiologicalProcess | double-strand break repair | ERCC5 RADX XRCC3 SMC5 PPP4R3B FBH1 BRCA2 ZFYVE26 TOP2B TP53BP1 | 6.30e-04 | 324 | 182 | 10 | GO:0006302 |
| GeneOntologyBiologicalProcess | DNA duplex unwinding | 6.35e-04 | 78 | 182 | 5 | GO:0032508 | |
| GeneOntologyBiologicalProcess | DNA repair | CCDC117 ERCC5 RADX POLG UPF1 XRCC3 SMC5 PPP4R3B FBH1 BRCA2 ASCC2 ZFYVE26 HDAC10 TOP2B TP53BP1 | 6.52e-04 | 648 | 182 | 15 | GO:0006281 |
| GeneOntologyBiologicalProcess | glossopharyngeal nerve development | 7.61e-04 | 5 | 182 | 2 | GO:0021563 | |
| GeneOntologyBiologicalProcess | centriole replication | 7.78e-04 | 47 | 182 | 4 | GO:0007099 | |
| GeneOntologyCellularComponent | protein phosphatase 4 complex | 1.23e-05 | 6 | 180 | 3 | GO:0030289 | |
| GeneOntologyCellularComponent | cytoplasmic region | MYO5B CEP162 CKAP5 ODAD2 WDR54 DNAH1 CFAP54 SPAG17 CFAP69 DNAH8 DYNC1H1 | 3.00e-04 | 360 | 180 | 11 | GO:0099568 |
| GeneOntologyCellularComponent | microtubule end | 3.12e-04 | 38 | 180 | 4 | GO:1990752 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | CEP162 CKAP5 ODAD2 WDR54 DNAH1 CFAP54 SPAG17 CFAP69 DNAH8 DYNC1H1 | 4.40e-04 | 317 | 180 | 10 | GO:0032838 |
| GeneOntologyCellularComponent | axoneme | 4.41e-04 | 207 | 180 | 8 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 4.55e-04 | 208 | 180 | 8 | GO:0097014 | |
| GeneOntologyCellularComponent | adherens junction | 5.16e-04 | 212 | 180 | 8 | GO:0005912 | |
| GeneOntologyCellularComponent | supramolecular fiber | COL3A1 GLYAT CACNA1S NCKAP1 CEP162 CKAP5 DYRK1A ARHGEF25 SPAG5 DNAH1 ADORA2A NDRG1 SCN5A NAV3 CDK5RAP2 MACF1 AKAP13 PRKD1 SPAG17 FERMT2 DNAH8 DYNC1H1 | 5.28e-04 | 1179 | 180 | 22 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | COL3A1 GLYAT CACNA1S NCKAP1 CEP162 CKAP5 DYRK1A ARHGEF25 SPAG5 DNAH1 ADORA2A NDRG1 SCN5A NAV3 CDK5RAP2 MACF1 AKAP13 PRKD1 SPAG17 FERMT2 DNAH8 DYNC1H1 | 5.78e-04 | 1187 | 180 | 22 | GO:0099081 |
| GeneOntologyCellularComponent | microtubule | GLYAT CEP162 CKAP5 DYRK1A SPAG5 DNAH1 NDRG1 NAV3 CDK5RAP2 MACF1 SPAG17 DNAH8 DYNC1H1 | 7.44e-04 | 533 | 180 | 13 | GO:0005874 |
| GeneOntologyCellularComponent | DNA repair complex | 9.79e-04 | 23 | 180 | 3 | GO:1990391 | |
| GeneOntologyCellularComponent | axonemal central apparatus | 1.08e-03 | 6 | 180 | 2 | GO:1990716 | |
| GeneOntologyCellularComponent | cell cortex | MYO5B LAMC2 KIAA1614 HMCN1 MACF1 AKAP13 PRKD1 FERMT2 DYNC1H1 EPB42 | 1.46e-03 | 371 | 180 | 10 | GO:0005938 |
| MousePheno | abnormal spinal cord ventral horn morphology | 1.46e-05 | 15 | 147 | 4 | MP:0005112 | |
| Domain | Interferon | 4.19e-07 | 17 | 178 | 5 | PF00143 | |
| Domain | INTERFERON_A_B_D | 4.19e-07 | 17 | 178 | 5 | PS00252 | |
| Domain | Interferon_alpha/beta/delta | 4.19e-07 | 17 | 178 | 5 | IPR000471 | |
| Domain | IFabd | 4.19e-07 | 17 | 178 | 5 | SM00076 | |
| Domain | PH_dom-like | FRMPD4 FRS3 ARHGEF11 ARHGEF25 PPP4R3B ARHGEF40 SNTG1 TLN2 AKAP13 PRKD1 TNS4 WDFY3 FERMT2 PHLPP2 | 6.08e-05 | 426 | 178 | 14 | IPR011993 |
| Domain | Nck-associated_protein-1 | 9.03e-05 | 2 | 178 | 2 | IPR019137 | |
| Domain | Nckap1 | 9.03e-05 | 2 | 178 | 2 | PF09735 | |
| Domain | - | 1.11e-04 | 50 | 178 | 5 | 1.20.1250.10 | |
| Domain | 4_helix_cytokine_core | 1.22e-04 | 51 | 178 | 5 | IPR012351 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.87e-04 | 14 | 178 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.87e-04 | 14 | 178 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.87e-04 | 14 | 178 | 3 | IPR013602 | |
| Domain | DHC_N2 | 2.87e-04 | 14 | 178 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 2.87e-04 | 14 | 178 | 3 | IPR011704 | |
| Domain | MT | 2.87e-04 | 14 | 178 | 3 | PF12777 | |
| Domain | AAA_8 | 2.87e-04 | 14 | 178 | 3 | PF12780 | |
| Domain | AAA_5 | 2.87e-04 | 14 | 178 | 3 | PF07728 | |
| Domain | DHC_fam | 3.56e-04 | 15 | 178 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 3.56e-04 | 15 | 178 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 3.56e-04 | 15 | 178 | 3 | IPR004273 | |
| Domain | - | FRS3 ARHGEF11 ARHGEF25 PPP4R3B ARHGEF40 SNTG1 TLN2 AKAP13 PRKD1 TNS4 FERMT2 PHLPP2 | 3.83e-04 | 391 | 178 | 12 | 2.30.29.30 |
| Domain | CH | 3.87e-04 | 65 | 178 | 5 | SM00033 | |
| Domain | HEAT_type_2 | 5.25e-04 | 17 | 178 | 3 | IPR021133 | |
| Domain | CH | 5.45e-04 | 70 | 178 | 5 | PF00307 | |
| Domain | - | 5.82e-04 | 71 | 178 | 5 | 1.10.418.10 | |
| Domain | CH | 6.61e-04 | 73 | 178 | 5 | PS50021 | |
| Domain | 4_helix_cytokine-like_core | 7.04e-04 | 74 | 178 | 5 | IPR009079 | |
| Domain | CH-domain | 7.48e-04 | 75 | 178 | 5 | IPR001715 | |
| Pathway | BIOCARTA_IFNA_PATHWAY | 1.69e-08 | 19 | 135 | 6 | MM1571 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY | 4.54e-08 | 22 | 135 | 6 | M47616 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 6.09e-08 | 23 | 135 | 6 | MM15634 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY | 6.09e-08 | 23 | 135 | 6 | M47452 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 8.06e-08 | 24 | 135 | 6 | M47908 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 1.36e-07 | 26 | 135 | 6 | M982 | |
| Pathway | WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY | 4.17e-07 | 31 | 135 | 6 | M39897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY | 4.17e-07 | 31 | 135 | 6 | M47964 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY | 4.22e-07 | 17 | 135 | 5 | M47564 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY | 5.80e-07 | 18 | 135 | 5 | M47539 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 7.44e-07 | 34 | 135 | 6 | MM15631 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY | 7.81e-07 | 19 | 135 | 5 | M47450 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 8.91e-07 | 35 | 135 | 6 | M48246 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY | 1.03e-06 | 20 | 135 | 5 | M47617 | |
| Pathway | WP_INTERFERONMEDIATED_SIGNALING | 1.26e-06 | 37 | 135 | 6 | M39785 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 1.35e-06 | 21 | 135 | 5 | M47909 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY | 1.73e-06 | 22 | 135 | 5 | M47897 | |
| Pathway | BIOCARTA_IL1R_PATHWAY | 2.36e-06 | 41 | 135 | 6 | MM1493 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY | 2.75e-06 | 24 | 135 | 5 | M47782 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY | 2.75e-06 | 24 | 135 | 5 | M47576 | |
| Pathway | WP_PI3KAKT_SIGNALING | FLT3 ITGA10 LAMC2 IFNA4 IFNA7 IFNA10 IFNA14 CHUK IFNA21 PIK3R6 PKN1 OSMR PHLPP2 VEGFA | 4.57e-06 | 339 | 135 | 14 | M39736 |
| Pathway | KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 5.05e-06 | 71 | 135 | 7 | M15913 | |
| Pathway | WP_CYTOSOLIC_DNASENSING_PATHWAY | 6.08e-06 | 73 | 135 | 7 | M39837 | |
| Pathway | BIOCARTA_CYTOKINE_PATHWAY | 6.16e-06 | 28 | 135 | 5 | MM1378 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 6.21e-06 | 136 | 135 | 9 | M42547 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 8.79e-06 | 30 | 135 | 5 | M936 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 9.48e-06 | 78 | 135 | 7 | M973 | |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 1.32e-05 | 82 | 135 | 7 | M1002 | |
| Pathway | KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY | 1.36e-05 | 55 | 135 | 6 | M11844 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 1.43e-05 | 33 | 135 | 5 | MM1379 | |
| Pathway | KEGG_REGULATION_OF_AUTOPHAGY | 1.93e-05 | 35 | 135 | 5 | M6382 | |
| Pathway | WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE | 3.31e-05 | 39 | 135 | 5 | MM15914 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 4.24e-05 | 98 | 135 | 7 | M48247 | |
| Pathway | KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY | 5.48e-05 | 102 | 135 | 7 | M3261 | |
| Pathway | WP_TOLLLIKE_RECEPTOR_SIGNALING | 5.83e-05 | 103 | 135 | 7 | M39434 | |
| Pathway | WP_HEPATITIS_B_INFECTION | 1.01e-04 | 151 | 135 | 8 | M39801 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 1.35e-04 | 52 | 135 | 5 | M13103 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 1.53e-04 | 120 | 135 | 7 | M48233 | |
| Pathway | WP_IL2_SIGNALING_PATHWAY | 1.85e-04 | 87 | 135 | 6 | MM15915 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 1.97e-04 | 88 | 135 | 6 | M16004 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 2.07e-04 | 126 | 135 | 7 | M45009 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | COL3A1 ITGA10 LAMC2 IFNA4 IFNA7 IFNA10 IFNA14 IFNA21 OSMR PHLPP2 VEGFA | 2.99e-04 | 326 | 135 | 11 | MM15917 |
| Pathway | WP_CANCER_PATHWAYS | FLT3 CASP8 LAMC2 ARHGEF11 F2 IFNA4 IFNA7 STAT2 IFNA10 IFNA14 CHUK IFNA21 BRCA2 VEGFA | 3.58e-04 | 507 | 135 | 14 | M48302 |
| Pathway | REACTOME_INTERFERON_SIGNALING | 3.62e-04 | 138 | 135 | 7 | MM15635 | |
| Pathway | PID_CD8_TCR_DOWNSTREAM_PATHWAY | 3.90e-04 | 65 | 135 | 5 | M272 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 7.10e-04 | 74 | 135 | 5 | M41807 | |
| Pathway | KEGG_JAK_STAT_SIGNALING_PATHWAY | 7.25e-04 | 155 | 135 | 7 | M17411 | |
| Pathway | WP_16P112_PROXIMAL_DELETION_SYNDROME | 8.01e-04 | 76 | 135 | 5 | M40057 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | NCKAP1 FRS3 ARHGEF11 ARHGEF25 ARHGEF40 KIDINS220 AKAP13 PKN1 FERMT2 DDX39B PHIP NCKAP1L | 1.29e-03 | 450 | 135 | 12 | M27078 |
| Pathway | WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS | 1.38e-03 | 127 | 135 | 6 | M42533 | |
| Pubmed | 3.15e-11 | 13 | 182 | 6 | 38660315 | ||
| Pubmed | MAGI1 CNTN4 PDE1B NCKAP1 HECTD4 CKAP5 DYRK1A CHD8 FYCO1 UPF1 BTBD9 ARHGEF11 EEF2 ICAM5 CDK5RAP2 MACF1 TLN2 RABGEF1 PKN1 PRKD1 WDFY3 PPP6R2 DYNC1H1 TP53BP1 LRRFIP1 | 4.96e-11 | 963 | 182 | 25 | 28671696 | |
| Pubmed | Translational regulation by HIV leader RNA, TAT, and interferon-inducible enzymes. | 4.85e-10 | 19 | 182 | 6 | 1708818 | |
| Pubmed | A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity. | 4.85e-10 | 19 | 182 | 6 | 24784232 | |
| Pubmed | TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. | 6.89e-10 | 20 | 182 | 6 | 11694501 | |
| Pubmed | High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. | 1.67e-09 | 11 | 182 | 5 | 6444699 | |
| Pubmed | Mechanism of SUMOylation-Mediated Regulation of Type I IFN Expression. | 1.67e-09 | 11 | 182 | 5 | 36681180 | |
| Pubmed | Type I interferon dependence of plasmacytoid dendritic cell activation and migration. | 1.67e-09 | 11 | 182 | 5 | 15795237 | |
| Pubmed | 1.67e-09 | 11 | 182 | 5 | 9794439 | ||
| Pubmed | 1.67e-09 | 11 | 182 | 5 | 18835032 | ||
| Pubmed | Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. | 1.67e-09 | 11 | 182 | 5 | 10448195 | |
| Pubmed | IFN-alpha can both protect against and promote the development of type 1 diabetes. | 1.67e-09 | 11 | 182 | 5 | 19120292 | |
| Pubmed | Effect of interferon-alpha on immediate early gene expression of murine cytomegalovirus. | 1.67e-09 | 11 | 182 | 5 | 8389790 | |
| Pubmed | The mouse IFN-alpha (Ifa) locus: correlation of physical and linkage maps by in situ hybridization. | 1.67e-09 | 11 | 182 | 5 | 3456887 | |
| Pubmed | 1.67e-09 | 11 | 182 | 5 | 25310498 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FAM120B NCKAP1 GARS1 CKAP5 ELP1 CASP8 CHD8 UPF1 ANKHD1 PDIA3 DECR1 GSTZ1 EEF2 ARHGEF40 SHCBP1 MACF1 POLR1B AKAP13 WDFY3 FERMT2 GCN1 DDX39B PHIP DYNC1H1 TOP2B TP53BP1 PMM2 | 2.55e-09 | 1353 | 182 | 27 | 29467282 |
| Pubmed | MAVS Deficiency Is Associated With a Reduced T Cell Response Upon Secondary RSV Infection in Mice. | 2.86e-09 | 12 | 182 | 5 | 33123150 | |
| Pubmed | A novel anti-viral role for STAT3 in IFN-α signalling responses. | 2.86e-09 | 12 | 182 | 5 | 27988795 | |
| Pubmed | 2.86e-09 | 12 | 182 | 5 | 8656058 | ||
| Pubmed | 2.86e-09 | 12 | 182 | 5 | 6188104 | ||
| Pubmed | Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice. | 2.86e-09 | 12 | 182 | 5 | 18716002 | |
| Pubmed | Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway. | 2.86e-09 | 12 | 182 | 5 | 16611902 | |
| Pubmed | 2.86e-09 | 12 | 182 | 5 | 30967261 | ||
| Pubmed | 2.86e-09 | 12 | 182 | 5 | 17434974 | ||
| Pubmed | 2.86e-09 | 12 | 182 | 5 | 8245849 | ||
| Pubmed | 2.86e-09 | 12 | 182 | 5 | 3017340 | ||
| Pubmed | Role of interferons in the regulation of cell proliferation, differentiation, and development. | 2.86e-09 | 12 | 182 | 5 | 7530016 | |
| Pubmed | 2.86e-09 | 12 | 182 | 5 | 9794206 | ||
| Pubmed | Isolation and mapping of four new DNA markers from mouse chromosome 4. | 2.86e-09 | 12 | 182 | 5 | 1360280 | |
| Pubmed | 2.86e-09 | 12 | 182 | 5 | 7601556 | ||
| Pubmed | 2.86e-09 | 12 | 182 | 5 | 16565497 | ||
| Pubmed | Regulation of effector and memory T-cell functions by type I interferon. | 2.86e-09 | 12 | 182 | 5 | 21320124 | |
| Pubmed | Evolution of the interferon alpha gene family in eutherian mammals. | 2.86e-09 | 12 | 182 | 5 | 17512142 | |
| Pubmed | 2.86e-09 | 12 | 182 | 5 | 9425112 | ||
| Pubmed | Repression of the murine interferon alpha 11 gene: identification of negatively acting sequences. | 2.86e-09 | 12 | 182 | 5 | 1886773 | |
| Pubmed | The physical separation of Lps and Ifa loci in BXH recombinant inbred mice. | 2.86e-09 | 12 | 182 | 5 | 2572648 | |
| Pubmed | Developmental control of IFN-alpha expression in murine embryos. | 2.86e-09 | 12 | 182 | 5 | 7925651 | |
| Pubmed | The role of type 1 interferons in coagulation induced by gram-negative bacteria. | 2.86e-09 | 12 | 182 | 5 | 32016282 | |
| Pubmed | Multiple pathways of interferon-induced gene expression in murine macrophages. | 2.86e-09 | 12 | 182 | 5 | 7684767 | |
| Pubmed | Ligation of CD180 inhibits IFN-α signaling in a Lyn-PI3K-BTK-dependent manner in B cells. | 2.86e-09 | 12 | 182 | 5 | 26277892 | |
| Pubmed | 2.86e-09 | 12 | 182 | 5 | 6689487 | ||
| Pubmed | Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection. | 2.86e-09 | 12 | 182 | 5 | 22912583 | |
| Pubmed | 2.86e-09 | 12 | 182 | 5 | 23747509 | ||
| Pubmed | 2.86e-09 | 12 | 182 | 5 | 18937499 | ||
| Pubmed | Structure and expression of a new murine interferon-alpha gene: MuIFN-alpha I9. | 2.86e-09 | 12 | 182 | 5 | 3758677 | |
| Pubmed | 2.86e-09 | 12 | 182 | 5 | 19406830 | ||
| Pubmed | 2.86e-09 | 12 | 182 | 5 | 22685550 | ||
| Pubmed | 2.86e-09 | 12 | 182 | 5 | 20038206 | ||
| Pubmed | Murine alpha/beta interferons inhibit benzo(a)pyrene activation and mutagenesis in mice. | 2.86e-09 | 12 | 182 | 5 | 8304945 | |
| Pubmed | 2.86e-09 | 12 | 182 | 5 | 11846978 | ||
| Pubmed | Identification of distal silencing elements in the murine interferon-A11 gene promoter. | 2.86e-09 | 12 | 182 | 5 | 8760352 | |
| Pubmed | Behavioral effects of mouse interferons-alpha and -gamma and human interferon-alpha in mice. | 2.86e-09 | 12 | 182 | 5 | 1422836 | |
| Pubmed | 2.86e-09 | 12 | 182 | 5 | 17277125 | ||
| Pubmed | 2.86e-09 | 12 | 182 | 5 | 17451966 | ||
| Pubmed | 2.86e-09 | 12 | 182 | 5 | 25897172 | ||
| Pubmed | A polymorphic trinucleotide repeat sequence mapping to distal mouse chromosome 4. | 2.86e-09 | 12 | 182 | 5 | 8672140 | |
| Pubmed | CHD8 SMC5 LRCH1 KMT2C SPON1 HELZ2 NAV2 MACF1 TLN2 AKAP11 WDFY3 GCN1 | 2.90e-09 | 225 | 182 | 12 | 12168954 | |
| Pubmed | Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. | 4.62e-09 | 13 | 182 | 5 | 12930842 | |
| Pubmed | 4.62e-09 | 13 | 182 | 5 | 2471809 | ||
| Pubmed | 4.62e-09 | 13 | 182 | 5 | 8438572 | ||
| Pubmed | 4.62e-09 | 13 | 182 | 5 | 9343822 | ||
| Pubmed | 4.62e-09 | 13 | 182 | 5 | 19635904 | ||
| Pubmed | 4.62e-09 | 13 | 182 | 5 | 19706714 | ||
| Pubmed | Organization, structure and expression of murine interferon alpha genes. | 4.62e-09 | 13 | 182 | 5 | 2987810 | |
| Pubmed | 4.62e-09 | 13 | 182 | 5 | 19130550 | ||
| Pubmed | 4.62e-09 | 13 | 182 | 5 | 21469099 | ||
| Pubmed | Effects of IFN alpha on late stages of HIV-1 replication cycle. | 4.62e-09 | 13 | 182 | 5 | 9865497 | |
| Pubmed | Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. | 4.62e-09 | 13 | 182 | 5 | 2014240 | |
| Pubmed | 4.62e-09 | 13 | 182 | 5 | 18005734 | ||
| Pubmed | 4.62e-09 | 13 | 182 | 5 | 12050368 | ||
| Pubmed | Isolation and bacterial expression of a murine alpha leukocyte interferon gene. | 4.62e-09 | 13 | 182 | 5 | 6094686 | |
| Pubmed | 4.62e-09 | 13 | 182 | 5 | 2993652 | ||
| Pubmed | 4.62e-09 | 13 | 182 | 5 | 1655578 | ||
| Pubmed | 4.62e-09 | 13 | 182 | 5 | 21263073 | ||
| Pubmed | Evidence for a different susceptibility of primate lentiviruses to type I interferons. | 4.62e-09 | 13 | 182 | 5 | 23255800 | |
| Pubmed | 4.62e-09 | 13 | 182 | 5 | 7523540 | ||
| Pubmed | 4.62e-09 | 13 | 182 | 5 | 23804712 | ||
| Pubmed | 4.62e-09 | 13 | 182 | 5 | 22431588 | ||
| Pubmed | Mouse interferon alpha and beta genes are linked at the centromere proximal region of chromosome 4. | 4.62e-09 | 13 | 182 | 5 | 3973562 | |
| Pubmed | 4.62e-09 | 13 | 182 | 5 | 22739040 | ||
| Pubmed | 4.62e-09 | 13 | 182 | 5 | 20065291 | ||
| Pubmed | 4.62e-09 | 13 | 182 | 5 | 9181467 | ||
| Pubmed | 4.62e-09 | 13 | 182 | 5 | 17723216 | ||
| Pubmed | 4.62e-09 | 13 | 182 | 5 | 20427526 | ||
| Pubmed | Sequencing and bacterial expression of a novel murine alpha interferon gene. | 4.62e-09 | 13 | 182 | 5 | 18726328 | |
| Pubmed | 4.62e-09 | 13 | 182 | 5 | 18572754 | ||
| Pubmed | 4.62e-09 | 13 | 182 | 5 | 15723075 | ||
| Pubmed | The RNA-editing enzyme ADAR1 controls innate immune responses to RNA. | 5.11e-09 | 27 | 182 | 6 | 25456137 | |
| Pubmed | 7.16e-09 | 14 | 182 | 5 | 22815848 | ||
| Pubmed | Dual regulatory roles of phosphatidylinositol 3-kinase in IFN signaling. | 7.16e-09 | 14 | 182 | 5 | 18981154 | |
| Pubmed | Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest. | 7.16e-09 | 14 | 182 | 5 | 8668211 | |
| Pubmed | Interferon induction by HIV glycoprotein 120: role of the V3 loop. | 7.16e-09 | 14 | 182 | 5 | 7526537 | |
| Pubmed | 7.16e-09 | 14 | 182 | 5 | 19559726 | ||
| Pubmed | Differential constitutive expression of interferon genes in early mouse embryos. | 7.16e-09 | 14 | 182 | 5 | 7654369 | |
| Pubmed | 7.16e-09 | 14 | 182 | 5 | 2552026 | ||
| Pubmed | Modulation of interferon-mediated inhibition of human immunodeficiency virus type 1 by Tat. | 7.16e-09 | 14 | 182 | 5 | 7532202 | |
| Pubmed | 7.16e-09 | 14 | 182 | 5 | 18200012 | ||
| Pubmed | Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. | 7.16e-09 | 14 | 182 | 5 | 18200009 | |
| Pubmed | A structural basis for interferon-alpha-receptor interactions. | 7.16e-09 | 14 | 182 | 5 | 17517919 | |
| Pubmed | 7.16e-09 | 14 | 182 | 5 | 25972534 | ||
| Interaction | YWHAZ interactions | HIVEP1 MAP7D3 PDE1B NCKAP1 CEP162 HECTD4 CKAP5 CEP192 SMC5 ZHX2 LRCH1 ANKRD55 RNF115 MAP3K3 SPAG5 RUSC2 ASXL3 SHCBP1 NAV2 CDK5RAP2 MACF1 RABGEF1 AKAP13 AKAP11 PRKD1 WDFY3 FERMT2 DYNC1H1 CFAP410 GABBR1 TP53BP1 | 4.01e-07 | 1319 | 176 | 31 | int:YWHAZ |
| Interaction | YWHAQ interactions | CACNA1S MAP7D3 NCKAP1 CEP162 HECTD4 DYRK1A CEP192 UPF1 SMC5 ZHX2 F2 ANKRD55 RNF115 MAP3K3 RUSC2 PPP4R3B EEF2 SHCBP1 NAV2 KCTD15 MACF1 RABGEF1 AKAP13 AKAP11 PRKD1 GCN1 DYNC1H1 CFAP410 | 4.53e-07 | 1118 | 176 | 28 | int:YWHAQ |
| Interaction | EGLN3 interactions | PPP4R1 TBC1D15 FAM120B MAP7D3 RADX TOM1 DMAC2 CKAP5 DYRK1A ELP1 CHD8 CEP192 ANKHD1 SUCLA2 LRCH1 LRCH3 CHUK EEF2 KIDINS220 BRCA2 CDK5RAP2 POLR1B AKAP13 AKAP11 PPP6R2 GCN1 DYNC1H1 CFAP410 | 7.90e-06 | 1296 | 176 | 28 | int:EGLN3 |
| Interaction | YWHAH interactions | MAGI1 HIVEP1 MAP7D3 NCKAP1 CEP162 HECTD4 CKAP5 DYRK1A CEP192 ANKRD55 RNF115 MAP3K3 RUSC2 NDRG1 SHCBP1 NAV2 MACF1 RABGEF1 AKAP13 AKAP11 PRKD1 NKTR HERC1 FERMT2 CFAP410 | 1.13e-05 | 1102 | 176 | 25 | int:YWHAH |
| Interaction | YWHAG interactions | MAGI1 HIVEP1 MAP7D3 NCKAP1 CEP162 HECTD4 CKAP5 DYRK1A CEP192 ANKRD55 RNF115 MAP3K3 LRCH3 RUSC2 NDRG1 SHCBP1 NAV2 MACF1 RABGEF1 AKAP13 AKAP11 PRKD1 NKTR DDX39B DYNC1H1 CFAP410 | 3.23e-05 | 1248 | 176 | 26 | int:YWHAG |
| Interaction | ZYX interactions | GARS1 UBAP1 CEP192 SPAG5 KIDINS220 MACF1 TLN2 AKAP13 AKAP11 PRKD1 FERMT2 PPP6R2 | 3.38e-05 | 329 | 176 | 12 | int:ZYX |
| Interaction | PFN1 interactions | ELP1 CEP192 UPF1 ANKHD1 ARHGEF11 PDIA3 STAT2 SPAG5 KIDINS220 CEP44 MACF1 AKAP13 PPP6R2 DDX39B TP53BP1 | 4.25e-05 | 509 | 176 | 15 | int:PFN1 |
| Cytoband | 9p22 | 4.62e-08 | 25 | 182 | 5 | 9p22 | |
| Cytoband | 15q15-q21 | 2.44e-07 | 4 | 182 | 3 | 15q15-q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p21 | 1.42e-04 | 124 | 182 | 5 | chr9p21 | |
| GeneFamily | Interferons | 2.24e-06 | 32 | 122 | 5 | 598 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.03e-03 | 66 | 122 | 4 | 722 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 1.17e-03 | 31 | 122 | 3 | 81 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | HIVEP1 NCKAP1 CKAP5 DYRK1A CASP8 TRAPPC8 SMC5 ZHX2 KIDINS220 BRCA2 PTPRM NAV3 MACF1 AKAP13 AKAP11 WDFY3 OSMR FERMT2 STK24 PHIP TP53BP1 LRRFIP1 PHLPP2 PMM2 NPAT | 1.26e-09 | 856 | 181 | 25 | M4500 |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 2.69e-07 | 39 | 181 | 6 | M41095 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_5 | 1.54e-06 | 29 | 181 | 5 | MM586 | |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 3.51e-06 | 34 | 181 | 5 | M41094 | |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | ABAT EFS LAMTOR5 DYRK1A OAS2 SMC5 ZHX2 SUCLA2 CHUK DECR1 KIDINS220 MICB DLEC1 TOP2B EPB42 VEGFA NCKAP1L | 8.60e-06 | 705 | 181 | 17 | M1410 |
| Coexpression | GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP | 1.02e-05 | 198 | 181 | 9 | M4462 | |
| Coexpression | GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN | 1.07e-05 | 199 | 181 | 9 | M7607 | |
| Coexpression | WORSCHECH_TUMOR_REJECTION_UP | 1.96e-05 | 80 | 181 | 6 | MM1229 | |
| Coexpression | LEE_AGING_NEOCORTEX_DN | 1.96e-05 | 80 | 181 | 6 | MM646 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_DN | 2.78e-05 | 85 | 181 | 6 | MM684 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 3.17e-05 | 87 | 181 | 6 | MM652 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_UP | 3.41e-05 | 27 | 181 | 4 | M40935 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 4.80e-05 | 300 | 181 | 10 | M8702 | |
| Coexpression | GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_DN | 6.91e-05 | 145 | 181 | 7 | M359 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 6.91e-05 | 145 | 181 | 7 | M1810 | |
| Coexpression | GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_UP | 7.12e-05 | 197 | 181 | 8 | M7682 | |
| Coexpression | ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP | XIRP1 BTBD9 ANKHD1 NDRG1 HECTD2 SPON1 SNTG1 MACF1 FERMT2 CFAP69 DYNC1H1 VEGFA | 7.71e-05 | 452 | 181 | 12 | M18685 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | MAP7D3 HECTD4 DYRK1A ELP1 CASP8 OAS2 TRAPPC8 SMC5 PPP4R3B KMT2C CD2 KIDINS220 MICB MACF1 AKAP13 AKAP11 HERC1 STK24 PHIP DYNC1H1 TOP2B LRRFIP1 NPAT NCKAP1L | 1.00e-04 | 1492 | 181 | 24 | M40023 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | HIVEP1 CKAP5 DYRK1A CASP8 TRAPPC8 SMC5 ZHX2 FERMT2 STK24 PHIP PHLPP2 PMM2 | 1.03e-04 | 466 | 181 | 12 | M13522 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | PDE1B CEP162 FRS3 CKAP5 FYCO1 CEP192 XRCC3 SMC5 ADAM28 SPAG5 LRCH3 CAPN13 CFAP54 BRCA2 HECTD2 SPON1 RPUSD2 MACF1 HERC1 CFAP410 TP53BP1 ADAMTSL2 DEUP1 | 1.61e-05 | 1060 | 172 | 23 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | MAGI1 ACAA1 POGK HECTD4 CKAP5 CHD8 SMC5 SPAG5 FBH1 RPUSD2 AKAP13 RGS17 CFAP69 PHIP TOP2B ADAMTSL2 PHLPP2 | 2.44e-05 | 654 | 172 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | MAGI1 CNTN4 MYO5B GREB1L CFAP54 PLXNA4 NAV2 PRKD1 STK24 VEGFA | 3.99e-05 | 251 | 172 | 10 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k2_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_200 | 6.28e-05 | 52 | 172 | 5 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k1_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | MAGI1 CEP162 TRIM41 UBAP1 GON4L SMC5 ANKHD1 KIAA1614 PPP4R3B BRCA2 HECTD2 ADAMTS20 MACF1 NKTR PHIP TOP2B GABBR1 PMM2 | 6.60e-05 | 780 | 172 | 18 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.16e-04 | 231 | 172 | 9 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k4_1000 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FRMPD4 ODAD2 DNAH1 HMCN1 ASXL3 NAV3 ADAMTS20 TLN2 SPAG17 USH2A | 4.76e-09 | 184 | 182 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FRMPD4 ODAD2 DNAH1 HMCN1 ASXL3 NAV3 ADAMTS20 TLN2 SPAG17 USH2A | 4.76e-09 | 184 | 182 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FRMPD4 ODAD2 DNAH1 HMCN1 ASXL3 NAV3 ADAMTS20 TLN2 SPAG17 USH2A | 4.76e-09 | 184 | 182 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL3A1 CNTN4 FRMPD4 AOX1 ASXL3 SPON1 PLXNA4 PRKD1 OSMR CFAP69 | 7.91e-09 | 194 | 182 | 10 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.06e-08 | 200 | 182 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-08 | 154 | 182 | 9 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-08 | 154 | 182 | 9 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.74e-08 | 191 | 182 | 9 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 1.02e-07 | 192 | 182 | 9 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.02e-07 | 192 | 182 | 9 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-07 | 192 | 182 | 9 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-07 | 195 | 182 | 9 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.16e-07 | 195 | 182 | 9 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 1.21e-07 | 196 | 182 | 9 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 1.21e-07 | 196 | 182 | 9 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.32e-07 | 198 | 182 | 9 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.38e-07 | 199 | 182 | 9 | 60919c2af31d39a2d36d7bc432e43dab2a4e05fb | |
| ToppCell | LPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.38e-07 | 199 | 182 | 9 | 6aca164bbbb961f34b1e6f1857f91ade5c059405 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.44e-07 | 200 | 182 | 9 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.70e-07 | 176 | 182 | 8 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.29e-07 | 178 | 182 | 8 | b1db59344c074c7c80169fc2c5cd5fc89f3fe463 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.29e-07 | 178 | 182 | 8 | 579cdc14f28b459e200ae2102e0bd4df8a2c0dcb | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 9.75e-07 | 185 | 182 | 8 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.10e-06 | 188 | 182 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-06 | 190 | 182 | 8 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-06 | 191 | 182 | 8 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.34e-06 | 193 | 182 | 8 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-06 | 193 | 182 | 8 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.41e-06 | 135 | 182 | 7 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.45e-06 | 195 | 182 | 8 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.50e-06 | 196 | 182 | 8 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.50e-06 | 196 | 182 | 8 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.62e-06 | 198 | 182 | 8 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.86e-06 | 157 | 182 | 7 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.15e-06 | 164 | 182 | 7 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.27e-06 | 169 | 182 | 7 | 16c52a0f6d96ecc1832922fce9b39691849f0d73 | |
| ToppCell | droplet-Liver-LIVER-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.17e-06 | 176 | 182 | 7 | 4d2fb51e71bed0d72f3d7f89d395744860885a5f | |
| ToppCell | droplet-Liver-LIVER-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.17e-06 | 176 | 182 | 7 | 4880fa20b50eb10358e08567e08559ef2954f237 | |
| ToppCell | droplet-Liver-LIVER-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.17e-06 | 176 | 182 | 7 | fcdddd949ca05b3ecde240db9e38296a6eab2d6a | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-06 | 177 | 182 | 7 | e8bb4f8ecd5e283efec966b9fc2040a6152d5551 | |
| ToppCell | COPD-Epithelial-Basal|World / Disease state, Lineage and Cell class | 9.81e-06 | 181 | 182 | 7 | 6d8a886b4afe729f8a05b9c0f4ea9375de735da4 | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.02e-05 | 182 | 182 | 7 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | COPD-Epithelial-Basal|COPD / Disease state, Lineage and Cell class | 1.05e-05 | 183 | 182 | 7 | 0f760e393edc91009bf6c7e02eeac039a1dfb4ed | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 185 | 182 | 7 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-05 | 186 | 182 | 7 | a558fd00053e7dd6216b01dc8e650c30cee451f1 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-05 | 186 | 182 | 7 | 75b1f342be5d6dbe0e7acd924a0ca75964f6bab0 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-05 | 186 | 182 | 7 | 0c3d195077de7b4c354c127a26116438aef29244 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.21e-05 | 187 | 182 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.21e-05 | 187 | 182 | 7 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.30e-05 | 189 | 182 | 7 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-05 | 190 | 182 | 7 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.39e-05 | 191 | 182 | 7 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-05 | 192 | 182 | 7 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 1.44e-05 | 192 | 182 | 7 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-05 | 192 | 182 | 7 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-05 | 192 | 182 | 7 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.49e-05 | 193 | 182 | 7 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.54e-05 | 194 | 182 | 7 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-05 | 194 | 182 | 7 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.54e-05 | 194 | 182 | 7 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 1.59e-05 | 195 | 182 | 7 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.59e-05 | 195 | 182 | 7 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-05 | 195 | 182 | 7 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-05 | 195 | 182 | 7 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 195 | 182 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 195 | 182 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-05 | 196 | 182 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-05 | 196 | 182 | 7 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.64e-05 | 196 | 182 | 7 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 1.64e-05 | 196 | 182 | 7 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.70e-05 | 197 | 182 | 7 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 1.75e-05 | 198 | 182 | 7 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-05 | 198 | 182 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.75e-05 | 198 | 182 | 7 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.81e-05 | 133 | 182 | 6 | 8ff1cf0ea1fc33fe8384c0e65c1ee1853b25a2ae | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Airway-Club|LPS_only / Treatment groups by lineage, cell group, cell type | 1.81e-05 | 199 | 182 | 7 | 165ac94b2d56072ad43358b5127d77555221e2d8 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.81e-05 | 199 | 182 | 7 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.81e-05 | 199 | 182 | 7 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.81e-05 | 199 | 182 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.81e-05 | 199 | 182 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1--L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.87e-05 | 200 | 182 | 7 | f3c710f0fc8a7bfb5371d1aff6e3d8f266953153 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.87e-05 | 200 | 182 | 7 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.87e-05 | 200 | 182 | 7 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-HPGD-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.87e-05 | 200 | 182 | 7 | 1ec2f322f936d2501330c53bb7c9390216c50cd1 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.87e-05 | 200 | 182 | 7 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-HPGD--L3-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.87e-05 | 200 | 182 | 7 | e250b2e45ef869f81cc40cc41f53d1e54e7848aa | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.87e-05 | 200 | 182 | 7 | 70a06fd7fb8de2c8ec3e3182e4476ced049daeae | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.87e-05 | 200 | 182 | 7 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.87e-05 | 200 | 182 | 7 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.87e-05 | 200 | 182 | 7 | 1639982d9d994918f7912d12d9d7cfcbc9da4145 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.87e-05 | 200 | 182 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | distal-Epithelial-Basal-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.87e-05 | 200 | 182 | 7 | 6f00d08e93f89b3575ebbd5c2f451e655d449ef3 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-HPGD|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.87e-05 | 200 | 182 | 7 | dea96adbd9a77fe50ff397d4bdeb4dc8f50de3b7 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.13e-05 | 154 | 182 | 6 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | Adult-Epithelial-basal_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.13e-05 | 154 | 182 | 6 | 38d346402417960044ae999e61f0092b46f2b591 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.13e-05 | 154 | 182 | 6 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.28e-05 | 155 | 182 | 6 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.28e-05 | 155 | 182 | 6 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-lymphocyte_of_B_lineage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-05 | 157 | 182 | 6 | 0fecc14959c4c9efc19d5c06475a890e0a30f148 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.47e-05 | 162 | 182 | 6 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| Drug | HCV-371 | 5.72e-08 | 6 | 181 | 4 | CID003013096 | |
| Drug | barium iodide | 1.97e-06 | 4 | 181 | 3 | CID000083684 | |
| Drug | R 842 | 2.61e-06 | 13 | 181 | 4 | CID000130714 | |
| Drug | poly rI:rC | 3.64e-06 | 30 | 181 | 5 | CID011979660 | |
| Drug | Iodipamide [606-17-7]; Up 200; 3.6uM; MCF7; HT_HG-U133A | FRS3 OAS2 ARHGEF11 ANKRD55 SPON1 MACF1 STK24 CFAP410 ZMYM6 PHLPP2 | 4.01e-06 | 196 | 181 | 10 | 5510_UP |
| Drug | B132 | 4.88e-06 | 5 | 181 | 3 | CID002734031 | |
| Drug | YNK01 | 8.48e-06 | 17 | 181 | 4 | CID000084071 | |
| Drug | N-hydroxyphenacetin | 9.71e-06 | 6 | 181 | 3 | CID000029539 | |
| Drug | podophyllin | 1.08e-05 | 18 | 181 | 4 | CID011979494 | |
| Drug | Yfrkd | 1.69e-05 | 7 | 181 | 3 | CID000129984 | |
| Drug | Biliton | 1.79e-05 | 41 | 181 | 5 | CID000002974 | |
| Drug | Halt | 2.08e-05 | 21 | 181 | 4 | CID000094635 | |
| Drug | NSC-163039 | 2.22e-05 | 190 | 181 | 9 | CID000005064 | |
| Drug | mitomycin C | COL3A1 ERCC5 XRCC3 MCOLN1 IFNA4 IFNA7 IFNA10 DECR1 BRCA2 TOP2B | 2.44e-05 | 241 | 181 | 10 | CID000005746 |
| Drug | AC1LAD6M | 2.69e-05 | 8 | 181 | 3 | CID000511663 | |
| Drug | 1hiv | 2.69e-05 | 8 | 181 | 3 | CID005479205 | |
| Drug | Chebi:36708 | 2.69e-05 | 8 | 181 | 3 | CID011966289 | |
| Drug | O4-[3-[(1S)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] O1-[3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (Z)-2-chlorobut-2-enedioate | 2.69e-05 | 8 | 181 | 3 | CID010011375 | |
| Drug | axitinib | 2.84e-05 | 45 | 181 | 5 | CID006450551 | |
| Drug | Tetrahydrozoline hydrochloride [522-48-5]; Down 200; 16.8uM; MCF7; HT_HG-U133A | 3.20e-05 | 199 | 181 | 9 | 6069_DN | |
| Drug | mitoxantrone | 3.32e-05 | 154 | 181 | 8 | CID000004212 | |
| Drug | Telaprevir | 4.01e-05 | 9 | 181 | 3 | CID003010818 | |
| Drug | boceprevir | 4.01e-05 | 9 | 181 | 3 | CID010324367 | |
| Drug | ridostin | 4.02e-05 | 116 | 181 | 7 | CID011979623 | |
| Drug | HMPV | 4.29e-05 | 25 | 181 | 4 | CID004444603 | |
| Drug | DTIC | 4.60e-05 | 81 | 181 | 6 | CID005281007 | |
| Drug | pipobroman | 5.69e-05 | 10 | 181 | 3 | CID000004842 | |
| Drug | dihydrokavain | 5.69e-05 | 10 | 181 | 3 | CID000098356 | |
| Drug | Quinoxaline | 5.77e-05 | 52 | 181 | 5 | CID000007045 | |
| Drug | benzylamide | 5.88e-05 | 27 | 181 | 4 | CID000010391 | |
| Drug | 2,4-dioxohept-5-enedioic acid | 6.29e-05 | 2 | 181 | 2 | CID006438741 | |
| Drug | SU 5614 | 6.29e-05 | 2 | 181 | 2 | ctd:C416849 | |
| Drug | 4-amino-2-fluorobutanoic acid | 6.29e-05 | 2 | 181 | 2 | CID002735915 | |
| Drug | gamma-carboline | 6.29e-05 | 2 | 181 | 2 | CID000130802 | |
| Drug | Vigabatrin | 6.29e-05 | 2 | 181 | 2 | DB01080 | |
| Drug | Coptidis rhizoma extract | 6.29e-05 | 2 | 181 | 2 | ctd:C107393 | |
| Drug | 3-dinitrobenzene | CCDC117 ABAT XIRP1 FRS3 ZHX2 F2 PDIA3 TMED4 KIDINS220 HMCN1 FERMT2 DYNC1H1 | 6.80e-05 | 388 | 181 | 12 | ctd:C017906 |
| Drug | illudin S | 6.81e-05 | 28 | 181 | 4 | CID000101109 | |
| Drug | AC1NRD2B | 6.81e-05 | 28 | 181 | 4 | CID005289317 | |
| Drug | 2'-deoxy-3'-thiacytidine | 6.88e-05 | 87 | 181 | 6 | CID000003877 | |
| Drug | flesinoxan | 7.78e-05 | 11 | 181 | 3 | CID000057347 | |
| Drug | SC-57099B | 7.78e-05 | 11 | 181 | 3 | CID000178079 | |
| Drug | theobromine | 7.86e-05 | 29 | 181 | 4 | CID000005429 | |
| Drug | NM 108 | 7.86e-05 | 29 | 181 | 4 | CID000500901 | |
| Drug | Beryllium | 8.26e-05 | 56 | 181 | 5 | CID000107649 | |
| Drug | penciclovir | 9.01e-05 | 30 | 181 | 4 | CID000004725 | |
| Drug | casopitant | 1.03e-04 | 12 | 181 | 3 | CID009917021 | |
| Drug | 5-aminolevulinic acid | 1.05e-04 | 135 | 181 | 7 | CID000000137 | |
| Disease | glucagon measurement, glucose tolerance test | 4.26e-06 | 6 | 178 | 3 | EFO_0004307, EFO_0008463 | |
| Disease | Non-Small Cell Lung Carcinoma | 4.72e-05 | 156 | 178 | 7 | C0007131 | |
| Disease | Malignant neoplasm of breast | XIRP1 LAMTOR5 ELP1 CASP8 XRCC3 TRAPPC8 MCOLN1 RNF115 CD2 EEF2 NDRG1 BRCA2 ICAM5 MACF1 ZFYVE26 DLEC1 TP53BP1 LRRFIP1 | 9.39e-05 | 1074 | 178 | 18 | C0006142 |
| Disease | Colorectal Carcinoma | COL3A1 CNTN4 EFS CASP8 ABCA10 KMT2C ICAM5 CPO PRKD1 TNS4 SPAG17 DNAH8 PHIP PMM2 | 9.89e-05 | 702 | 178 | 14 | C0009402 |
| Disease | Bipolar Disorder | MAGI1 CNTN4 GLYAT POLG TOM1 CASP8 GSTZ1 BRCA2 DNAH8 DKK4 VEGFA | 1.63e-04 | 477 | 178 | 11 | C0005586 |
| Disease | apolipoprotein A 1 measurement | FLT3 XIRP1 MYO5B ITGA10 ARHGEF25 RNF115 SPON1 MACF1 RGS17 DLEC1 HERC1 PHIP TP53BP1 LRRFIP1 VEGFA | 2.07e-04 | 848 | 178 | 15 | EFO_0004614 |
| Disease | bullous pemphigoid (is_marker_for) | 2.15e-04 | 4 | 178 | 2 | DOID:8506 (is_marker_for) | |
| Disease | Neurodevelopmental Disorders | 2.56e-04 | 93 | 178 | 5 | C1535926 | |
| Disease | BREAST CANCER | 2.65e-04 | 21 | 178 | 3 | 114480 | |
| Disease | Intellectual Disability | FRMPD4 MAP7D3 GON4L CHD8 KMT2C MACF1 PHIP DYNC1H1 ZMYM6 PMM2 | 4.09e-04 | 447 | 178 | 10 | C3714756 |
| Disease | MEDULLOBLASTOMA | 5.34e-04 | 6 | 178 | 2 | 155255 | |
| Disease | Medulloblastoma | 5.34e-04 | 6 | 178 | 2 | cv:C0025149 | |
| Disease | Liver Failure | 5.34e-04 | 6 | 178 | 2 | C0085605 | |
| Disease | Malignant tumor of breast | 5.68e-04 | 27 | 178 | 3 | cv:C0006142 | |
| Disease | Breast neoplasm | 5.68e-04 | 27 | 178 | 3 | cv:C1458155 | |
| Disease | Familial cancer of breast | 5.68e-04 | 27 | 178 | 3 | cv:C0346153 | |
| Disease | Carcinoma, Granular Cell | 7.06e-04 | 116 | 178 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 7.06e-04 | 116 | 178 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 7.06e-04 | 116 | 178 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 7.06e-04 | 116 | 178 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 7.06e-04 | 116 | 178 | 5 | C0205641 | |
| Disease | Adenocarcinoma | 7.06e-04 | 116 | 178 | 5 | C0001418 | |
| Disease | docosahexaenoic acid measurement, sex interaction measurement | 7.45e-04 | 7 | 178 | 2 | EFO_0007761, EFO_0008343 | |
| Disease | Glioma | 1.27e-03 | 9 | 178 | 2 | cv:C0017638 | |
| Disease | Esophageal Neoplasms | 1.29e-03 | 78 | 178 | 4 | C0014859 | |
| Disease | Malignant neoplasm of esophagus | 1.29e-03 | 78 | 178 | 4 | C0546837 | |
| Disease | Glioblastoma | 1.35e-03 | 79 | 178 | 4 | C0017636 | |
| Disease | Mammary Carcinoma, Human | LAMTOR5 ELP1 CASP8 XRCC3 RNF115 EEF2 NDRG1 BRCA2 ICAM5 TP53BP1 | 1.39e-03 | 525 | 178 | 10 | C4704874 |
| Disease | Mammary Neoplasms, Human | LAMTOR5 ELP1 CASP8 XRCC3 RNF115 EEF2 NDRG1 BRCA2 ICAM5 TP53BP1 | 1.39e-03 | 525 | 178 | 10 | C1257931 |
| Disease | Mammary Neoplasms | LAMTOR5 ELP1 CASP8 XRCC3 RNF115 EEF2 NDRG1 BRCA2 ICAM5 TP53BP1 | 1.43e-03 | 527 | 178 | 10 | C1458155 |
| Disease | osteoarthritis, hand | 1.44e-03 | 37 | 178 | 3 | EFO_1000789 | |
| Disease | medulloblastoma (is_implicated_in) | 1.58e-03 | 10 | 178 | 2 | DOID:0050902 (is_implicated_in) | |
| Disease | Facies | 1.58e-03 | 10 | 178 | 2 | C0282631 | |
| Disease | Profound Mental Retardation | 1.58e-03 | 139 | 178 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.58e-03 | 139 | 178 | 5 | C0025363 | |
| Disease | Mental deficiency | 1.58e-03 | 139 | 178 | 5 | C0917816 | |
| Disease | Breast Carcinoma | LAMTOR5 ELP1 CASP8 XRCC3 RNF115 EEF2 NDRG1 BRCA2 ICAM5 TP53BP1 | 1.66e-03 | 538 | 178 | 10 | C0678222 |
| Disease | corpus callosum anterior volume measurement | 1.68e-03 | 39 | 178 | 3 | EFO_0010295 | |
| Disease | Giant Cell Glioblastoma | 1.70e-03 | 84 | 178 | 4 | C0334588 | |
| Disease | nicotine dependence symptom count | 1.79e-03 | 285 | 178 | 7 | EFO_0009262 | |
| Disease | autoimmune hepatitis (is_marker_for) | 1.92e-03 | 11 | 178 | 2 | DOID:2048 (is_marker_for) | |
| Disease | glomerulonephritis (is_implicated_in) | 1.92e-03 | 11 | 178 | 2 | DOID:2921 (is_implicated_in) | |
| Disease | Ashkenazi Jewish disorders | 1.92e-03 | 11 | 178 | 2 | cv:CN118946 | |
| Disease | tuberculosis | 2.05e-03 | 216 | 178 | 6 | MONDO_0018076 | |
| Disease | Charcot-Marie-Tooth disease | 2.08e-03 | 42 | 178 | 3 | cv:C0007959 | |
| Disease | spleen volume | 2.23e-03 | 43 | 178 | 3 | EFO_0600047 | |
| Disease | rotator cuff tear, shoulder impingement syndrome | 2.30e-03 | 12 | 178 | 2 | EFO_1001178, EFO_1001250 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 2.30e-03 | 12 | 178 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | 1-stearoyl-2-linoleoyl-GPI (18:0/18:2) measurement | 2.70e-03 | 13 | 178 | 2 | EFO_0800413 | |
| Disease | autoimmune hepatitis (is_implicated_in) | 2.70e-03 | 13 | 178 | 2 | DOID:2048 (is_implicated_in) | |
| Disease | Thrombus | 2.71e-03 | 46 | 178 | 3 | C0087086 | |
| Disease | brain connectivity measurement | 3.08e-03 | 400 | 178 | 8 | EFO_0005210 | |
| Disease | Thrombosis | 3.24e-03 | 49 | 178 | 3 | C0040053 | |
| Disease | Liver Cirrhosis | 3.56e-03 | 103 | 178 | 4 | C0023890 | |
| Disease | brain edema (biomarker_via_orthology) | 3.61e-03 | 15 | 178 | 2 | DOID:4724 (biomarker_via_orthology) | |
| Disease | Seizures, Focal | 3.68e-03 | 104 | 178 | 4 | C0751495 | |
| Disease | serum gamma-glutamyl transferase measurement | GLYAT HECTD4 DYRK1A GON4L CASP8 ARHGEF11 PTPRM NAV2 AKAP13 PPP6R2 GCN1 TP53BP1 VEGFA | 3.78e-03 | 914 | 178 | 13 | EFO_0004532 |
| Disease | Fibrosis, Liver | 3.81e-03 | 105 | 178 | 4 | C0239946 | |
| Disease | abdominal adipose tissue measurement | 4.05e-03 | 53 | 178 | 3 | EFO_0803316 | |
| Disease | melanoma | 4.05e-03 | 248 | 178 | 6 | C0025202 | |
| Disease | Spondyloepiphyseal Dysplasia | 4.11e-03 | 16 | 178 | 2 | C0038015 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 4.11e-03 | 16 | 178 | 2 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 4.11e-03 | 16 | 178 | 2 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 4.11e-03 | 16 | 178 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 4.11e-03 | 16 | 178 | 2 | C0025237 | |
| Disease | Rheumatoid Arthritis | 4.17e-03 | 174 | 178 | 5 | C0003873 | |
| Disease | MAJOR AFFECTIVE DISORDER 2 | 4.64e-03 | 17 | 178 | 2 | C1839839 | |
| Disease | Inborn Errors of Metabolism | 4.64e-03 | 17 | 178 | 2 | C0025521 | |
| Disease | Van Buchem disease | 4.64e-03 | 17 | 178 | 2 | C0432272 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 4.64e-03 | 17 | 178 | 2 | cv:C0270914 | |
| Disease | Glioblastoma Multiforme | 4.65e-03 | 111 | 178 | 4 | C1621958 | |
| Disease | myeloid white cell count | FLT3 HECTD4 DYRK1A ITGA10 CASP8 KIAA1614 NDRG1 POLR1B TLN2 AKAP11 SNX11 SPAG17 VEGFA | 4.65e-03 | 937 | 178 | 13 | EFO_0007988 |
| Disease | Myeloid Leukemia | 5.20e-03 | 18 | 178 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 5.20e-03 | 18 | 178 | 2 | C0023466 | |
| Disease | heart failure | 5.40e-03 | 185 | 178 | 5 | EFO_0003144 | |
| Disease | sleep apnea measurement | 5.43e-03 | 116 | 178 | 4 | EFO_0007817 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 5.48e-03 | 264 | 178 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | prostate cancer (is_implicated_in) | 5.59e-03 | 117 | 178 | 4 | DOID:10283 (is_implicated_in) | |
| Disease | diet measurement, HOMA-B | 5.78e-03 | 19 | 178 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | Osteochondrodysplasias | 5.78e-03 | 19 | 178 | 2 | C0029422 | |
| Disease | Dyschondroplasias | 5.78e-03 | 19 | 178 | 2 | C0013366 | |
| Disease | response to methotrexate, neurotoxicity | 5.78e-03 | 19 | 178 | 2 | EFO_0011057, GO_0031427 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QNSLDAPMEDCVISI | 611 | P16452 | |
| SIPGILDVICEEMDQ | 121 | Q8IWD4 | |
| LDVICEEMDQTTGEP | 126 | Q8IWD4 | |
| EEMDQTTGEPQCEVA | 131 | Q8IWD4 | |
| GSSCVDITPIEMVTQ | 2911 | Q96N23 | |
| GVSQTDCNIMQDPDF | 1941 | Q9HCK8 | |
| CQEMPSLEVITLSVN | 36 | O43822 | |
| MEPEPVEDCVQSTLA | 1 | Q8TER5 | |
| TADLEQAVEVMCFVP | 316 | Q86VW2 | |
| VVHMCPTIGSNVEEI | 41 | A6NH57 | |
| TGDESEMEQVLCSLP | 726 | Q8WWZ4 | |
| STPICGNQLVEMGED | 406 | Q9UKQ2 | |
| EGQVACLFEDVVPMN | 161 | P29274 | |
| QLEPVTGQVSVLVMC | 106 | Q13838 | |
| NTTLTCEVMNGTDPE | 141 | P06729 | |
| PAMCGVELDSLISQV | 461 | Q9H1I8 | |
| ATAEQCGQETPLENM | 46 | Q13304 | |
| EEMDSITEVPANCSV | 1536 | Q12802 | |
| LCEAQEAAMPEIQEQ | 401 | O15085 | |
| NPEITALQTMLAECQ | 231 | Q9C0F1 | |
| SMDVTVGESIVLPCQ | 506 | Q8IWV2 | |
| LITNIDMEPCTVDPQ | 1811 | Q9UKA4 | |
| QEPMEGTNVVVCVTV | 376 | Q6MZZ7 | |
| TNCQEQPGDQVAMVE | 391 | Q3KP44 | |
| LVEEMLPNCEVVGVD | 221 | Q9NW81 | |
| EESPMTGVCVQQSPV | 746 | Q13627 | |
| TSPCEAELQELMEQI | 11 | Q05D60 | |
| LPEAQIQPTCEETME | 321 | Q8IVL8 | |
| IQPTCEETMEAVLSV | 326 | Q8IVL8 | |
| PQEEMTVVIDQLEVC | 526 | Q9C0F0 | |
| GQVVEEMCDQSTRPC | 1506 | P59510 | |
| DIVMDVGCSINPAID | 1186 | Q06278 | |
| QMACPDENVSSGELR | 246 | Q96SN8 | |
| IMNVSDCIPDAIEVV | 796 | Q99650 | |
| QMLCVPVNEDIPEVS | 251 | Q9UJ41 | |
| MESIQVLEECQNPTA | 61 | Q9UGC6 | |
| TFDIDPMVVTDCIQV | 181 | Q9GZU1 | |
| EINVLEPVMSQLSNC | 581 | Q14207 | |
| EQIMDSPRQCVTPSE | 51 | Q6NSI4 | |
| ACVIQEVGVEETPLM | 121 | P01566 | |
| ACVIQEVGVEETPLM | 121 | P01570 | |
| VDERNECGQTPLMIA | 31 | Q9ULH0 | |
| GVVNLECMFETPERV | 641 | Q15139 | |
| MELDVSCNEIQTIPS | 176 | Q96II8 | |
| GVCQMEEPLLVNVDK | 261 | Q8NEZ4 | |
| QVVDMLVECPKGSEV | 701 | Q96QZ7 | |
| DTEDMPVGQDSEICL | 1326 | Q9BQS8 | |
| PSINCTVDEMTEAVE | 406 | Q9UBS5 | |
| CVVTPQDGETSAQMI | 696 | O15111 | |
| PDFNTVVVCPQEQDM | 51 | Q6IB77 | |
| QEELETCMINQAPGC | 191 | P80404 | |
| PACESGVEDDQMAQI | 1966 | Q15751 | |
| GICNVTVDDLCQIMP | 546 | Q5U5R9 | |
| ACVIQEVGVEETPLM | 121 | P01568 | |
| VPRTLQELQAACGME | 556 | Q5VZ46 | |
| IVGEMEQKENCVPVF | 626 | Q5VYM1 | |
| AEQIVCEMGEAKPSQ | 911 | Q9HCM2 | |
| EPSVSEGQMVTVTCA | 331 | Q9UMF0 | |
| EVFPEIGDVMCNSVN | 166 | Q719H9 | |
| NQMSIDELSPCEEEA | 506 | Q01064 | |
| MVEGLVLINVNPCAE | 156 | Q92597 | |
| EDINGCPRSQSQMIE | 126 | Q8IVL0 | |
| IQMVSFEEQCISLGP | 826 | Q6ZU69 | |
| DELCQEVPSVFVNLM | 651 | Q96JB1 | |
| ACVIQEVGVEETPLM | 121 | P01567 | |
| GPCSEEEEFQQDVMA | 531 | P54098 | |
| CVMDLEPQDIQGVRT | 521 | Q96JB8 | |
| QNLSVCPEEESIIMS | 446 | P55160 | |
| PGNITDTMVCASVQE | 211 | Q9UBX7 | |
| MELDVSCNEITALPQ | 191 | Q9Y2L9 | |
| TSDGRVVPESQCQME | 766 | Q86TH1 | |
| PCTQTELAMIGEEEC | 606 | O95163 | |
| TPDEQLEMANCQAVI | 2126 | Q92616 | |
| PPMVNVTCSEVSEGN | 206 | Q29980 | |
| EVAQMGNADETPICL | 356 | Q9P215 | |
| INVVIEQMICDTDPE | 416 | Q5MIZ7 | |
| MEGCLAVAEVTLPTN | 2836 | Q9Y4D8 | |
| EMVNTICDVLQEPEQ | 36 | P29728 | |
| GDLNECVSPQEAAAM | 641 | Q9C091 | |
| VQNLSVCPEDESIIM | 446 | Q9Y2A7 | |
| LESGQPVQCESDVIM | 461 | Q9UPN3 | |
| IQEPADVSMEIGSNV | 796 | Q96RW7 | |
| VISNMVVLPDCELNT | 126 | Q6ZMV5 | |
| IDESTQATEPECMVP | 646 | Q92900 | |
| CDVRDPDMVQNTVSE | 116 | Q16698 | |
| MENQDALVCISESVP | 176 | P36888 | |
| VPEDFQERMEQQCIG | 141 | Q9P2D7 | |
| IENDNGTVRCEMPEL | 1491 | Q14008 | |
| VDEAQDCTPAIMNIV | 646 | Q8NFZ0 | |
| AESVCMTVQTLLGDP | 311 | Q969S8 | |
| CPENEEMVLSNSRIG | 2256 | P51587 | |
| VNDVCTTMEDATPIL | 86 | Q9UBT3 | |
| GQALADACQMEPEEV | 1811 | Q13698 | |
| CEEDLVVGEMNQPAI | 756 | Q14CM0 | |
| QCNSINVMEEPVIIT | 106 | O43559 | |
| DRVILTMCQEQGAQP | 2161 | Q3T8J9 | |
| EQTVHAEEGIPMSCQ | 231 | Q7Z7H3 | |
| ESMENSCPQVTEVTA | 421 | Q5TB80 | |
| SSPAIQEMVQCVTEL | 531 | O43281 | |
| ELCGVMTISDSPREQ | 201 | Q14790 | |
| PPQVNVEVFCNTSME | 306 | Q8IWC1 | |
| GDEVTMADLCLVPQV | 156 | O43708 | |
| DIPVVCLESDNGNIM | 61 | O43504 | |
| PDNECVTDLVLQVNM | 791 | O75578 | |
| MDGCLDTETPTVSIQ | 406 | Q8TEP8 | |
| LPEQEILIQSVCETM | 2131 | Q14204 | |
| NGFSCSVMPETEEVV | 466 | Q13753 | |
| SVMPETEEVVCNNCP | 471 | Q13753 | |
| METGETCISANPLNV | 1296 | P02461 | |
| MPAALVENSQVICEV | 1 | Q9UFF9 | |
| DPMVQCIIEESGEHI | 531 | P13639 | |
| MNLRGCEVTPDVNIS | 421 | Q96AC1 | |
| VCPEGLSMEQVEQGV | 941 | Q9BYK8 | |
| IVPMENVATIADCAS | 421 | Q96Q07 | |
| TTIIAQNPEAPMIEC | 316 | A5D8W1 | |
| GSMEFQCQASDLIPE | 1476 | Q9Y238 | |
| MEQELQASVGPSCVS | 216 | Q8N4L8 | |
| QEVPMCTGPEARQEV | 411 | Q96EK7 | |
| QQCMEELVSLITQDP | 51 | O75170 | |
| VLFVNMNCLTEVPAE | 121 | A6NM36 | |
| CMVEVPQELETSTGH | 456 | Q32MZ4 | |
| EGEFIPETSEQCMLD | 201 | Q99759 | |
| TSVVMLNDVDPAQLC | 1281 | P28827 | |
| MLNVSPIGRSCSQEE | 126 | O15305 | |
| GQEQEPVMTLDTQQC | 171 | Q8N2Y8 | |
| VETDVMNQETDPLCA | 486 | Q8IZ73 | |
| PEQQGVMCVIEKTVD | 156 | O75445 | |
| IIDEEETQFMSNCPV | 116 | Q9HCB6 | |
| SVPEIEACVQGRSTM | 131 | Q9Y5W9 | |
| MTPNPVQTLQEEAVC | 6 | Q8WV44 | |
| DCLIPMGITSENVAE | 176 | P09110 | |
| TVTQEQVDMGLECPV | 216 | Q9Y4L5 | |
| TCLTPNLVEMESQEA | 306 | Q96R06 | |
| TLCMVSQTVPEPDQG | 766 | P52630 | |
| CSVVGQQATEEMLLP | 241 | Q8TF05 | |
| MAEQQGRELEAECPV | 1 | Q96D59 | |
| DEDVGMNCREVTFVP | 86 | Q02880 | |
| DVLQTDDNMEICTPD | 1121 | P30414 | |
| LMIQEQDVICVSGEP | 36 | Q9NSN8 | |
| AEEACPGISDTMVAQ | 411 | Q9Y6E0 | |
| ENMLIPVVGTLQECA | 646 | Q5T2S8 | |
| IQENIFGICPHMTED | 236 | P30101 | |
| IEAAQAQQTPETCMR | 176 | Q5UE93 | |
| IPTVGCVTAMEILNE | 866 | P28715 | |
| QEEQILEIDCTMLTP | 171 | P41250 | |
| CNSENNAVDMPLVII | 2211 | Q8IVL1 | |
| QMLTSQAPCVDGFEE | 641 | Q14524 | |
| QLDMEPQGCLVAEVT | 461 | Q16512 | |
| MELCARTDPSEQVEG | 596 | Q8NEM2 | |
| ACVIQEVGVEETPLM | 121 | P05014 | |
| EINPMVEDSDGAVLC | 256 | Q9P2R7 | |
| CEVLDPEGNTFQVMA | 1581 | Q6Q759 | |
| IELGCSTPLMEASQE | 531 | Q8IWZ3 | |
| AQPQELVMFEEVSVC | 211 | O14709 | |
| ANIVISSCEEPRMQV | 716 | Q9UPR6 | |
| MEELTVIQCTSQELP | 176 | Q6ZSR9 | |
| QMLSPSERQCVETVV | 386 | Q9NZ09 | |
| GEELCMVQAQVPNQT | 136 | Q14587 | |
| EVLEMQEDCPEAQIG | 3261 | Q8IZQ1 | |
| TMQECEVLGEEIGLP | 2091 | Q9C0A1 | |
| NCREEQLIPQMGVTS | 611 | Q8WWQ0 | |
| RIQEEATNPDLGCMI | 121 | Q6ZVD8 | |
| TNSMVDIPIVLINGC | 366 | Q8IZW8 | |
| EEVFPETGDVMCNSV | 191 | Q96SI1 | |
| TGAIPVTQACLMEDI | 406 | O60784 | |
| GCTVELQEMPLVQEL | 371 | Q7Z404 | |
| PVGKCEVLEVSQEMI | 556 | Q9HBJ7 | |
| NIGIQTMECSLRVPE | 1151 | Q12888 | |
| DVGEDENVVMTPCPT | 641 | Q8TC07 | |
| CMVRTSQVVEQDVPE | 11 | Q9Y6X8 | |
| CFIEEIPDETMVIGN | 41 | Q7Z7H5 | |
| PQCVICGEILSSENM | 766 | O95789 | |
| VIFSLEQEEPCMLDG | 56 | Q5JVG2 | |
| ACGPMEIDSALNTVQ | 1046 | Q9Y4G6 | |
| MAQCVQSVQELIPDS | 1 | Q9Y2L5 | |
| CGQDQVTVAMTPRSE | 186 | P00734 | |
| QCQEDERNGLEAPMT | 116 | Q8N823 | |
| ETLELIDHMQCGVTP | 236 | Q00G26 | |
| VTNMGQEVILRCDPS | 31 | A0A087X0K7 | |
| GLECVPTEESNITMQ | 91 | P15692 | |
| CMEDNPDSLVNQEVL | 361 | Q9H9Y6 | |
| EGQIPVTCRIEEMEN | 301 | Q8IY18 | |
| DPTMCLEVTEQSLDQ | 1606 | Q68DK2 | |
| LGSEEPTEGDVQCMR | 81 | Q702N8 | |
| QMCPEEGQASQELQT | 171 | A6NGD5 | |
| QVCTTEPLDGVMLEK | 1801 | P15822 | |
| SPVLCINQVTEAMEE | 251 | O43542 | |
| ATEPAQGQDCVADMV | 171 | Q9H977 | |
| TVMCDQGLDPEIILQ | 1666 | Q9ULV0 |